GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Ypsomed Holding AG (CHIX:YPSNz) » Definitions » Capex-to-Operating-Cash-Flow

Ypsomed Holding AG (CHIX:YPSNZ) Capex-to-Operating-Cash-Flow : 2.06 (As of Sep. 2024)


View and export this data going back to 2013. Start your Free Trial

What is Ypsomed Holding AG Capex-to-Operating-Cash-Flow?

Capex-to-Operating-Cash-Flow assesses how much of a company’s cash flow from operations is being devoted to capital expenditure. It’s also useful to distinguish whether the company is capital intensive or not.

Ypsomed Holding AG's Capital Expenditure for the six months ended in Sep. 2024 was CHF-137.95 Mil. Its Cash Flow from Operations for the six months ended in Sep. 2024 was CHF66.90 Mil.

Hence, Ypsomed Holding AG's Capex-to-Operating-Cash-Flow for the six months ended in Sep. 2024 was 2.06.


Ypsomed Holding AG Capex-to-Operating-Cash-Flow Historical Data

The historical data trend for Ypsomed Holding AG's Capex-to-Operating-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ypsomed Holding AG Capex-to-Operating-Cash-Flow Chart

Ypsomed Holding AG Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Capex-to-Operating-Cash-Flow
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.42 1.48 1.49 1.31 1.20

Ypsomed Holding AG Semi-Annual Data
Mar15 Sep15 Mar16 Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24
Capex-to-Operating-Cash-Flow Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.20 1.44 1.23 1.17 2.06

Competitive Comparison of Ypsomed Holding AG's Capex-to-Operating-Cash-Flow

For the Medical Instruments & Supplies subindustry, Ypsomed Holding AG's Capex-to-Operating-Cash-Flow, along with its competitors' market caps and Capex-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Ypsomed Holding AG's Capex-to-Operating-Cash-Flow Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Ypsomed Holding AG's Capex-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Ypsomed Holding AG's Capex-to-Operating-Cash-Flow falls into.



Ypsomed Holding AG Capex-to-Operating-Cash-Flow Calculation

Ypsomed Holding AG's Capex-to-Operating-Cash-Flow for the fiscal year that ended in Mar. 2024 is calculated as

Capex-to-Operating-Cash-Flow=- Capital Expenditure / Cash Flow from Operations
=- (-195.312) / 163.224
=1.20

Ypsomed Holding AG's Capex-to-Operating-Cash-Flow for the quarter that ended in Sep. 2024 is calculated as

Capex-to-Operating-Cash-Flow=- Capital Expenditure / Cash Flow from Operations
=- (-137.954) / 66.896
=2.06

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Ypsomed Holding AG  (CHIX:YPSNz) Capex-to-Operating-Cash-Flow Explanation

Capex-to-Operating-Cash-Flow ratio assesses how much of a company’s Cash Flow from Operations is being devoted to Capital Expenditure. It is a good indicator in terms of how much the company is focused on growth. In general, a high Capex-to-Operating-Cash-Flow ratio indicates that the company is investing more in physical assets and is focused on growth and expansion. Conversely, lower ratio could indicate that a company has reached maturity and is no longer pursuing aggressive growth.

Moreover, the ratio is also useful to distinguish whether the company is capital intensive or not. If the ratio is large, then the company tends to be capital intensive. Lower ratio suggests that it’s a capital-light business. The ratio can be combined with ROIC % to identify whether the company is an asset-light business that has a high return on invested capital. This is one question investors commonly ask to see if a company qualifies as a good company.


Ypsomed Holding AG Capex-to-Operating-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Ypsomed Holding AG's Capex-to-Operating-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.


Ypsomed Holding AG Business Description

Traded in Other Exchanges
Address
Brunnmattstrasse 6, Burgdorf, CHE, 3401
Ypsomed Holding AG is a Swiss company that develops and manufactures injection and infusion systems that allow patients to self-administer medication. Specifically, the company focuses on ensuring the ease of diabetes and insulin injection. The company offers various products such as pen needles with a unique click-on function. The company operates under two reportable segments: diabetes care and delivery systems goods and services. Diabetes care and delivery systems goods and services.

Ypsomed Holding AG Headlines

No Headlines